-
1دورية أكاديمية
المؤلفون: Puente, Javier, Anido, Urbano, Angel Climent, Miguel, Gonzalez-Billalabeitia, Enrique, Lainez, Nuria, Lambea, Julio, Pablo Maroto, Jose, Jose Mendez-Vidal, Maria, Montesa, Alvaro, Rodriguez, Angel, Zambrana, Curro, Gonzalez-del-Alba, Aranzazu
المساهمون: Gonzalez-del-Alba, Aranzazu Hosp Univ Puerta Hierro Majadahonda, Med Ongol Dept, Calle Joaquin Rodrigo 2, Madrid 28222, Spain, Puente, Javier Hosp Clin San Carlos, CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain, Anido, Urbano Complejo Hosp Univ Santiago, Oncol Dept, Santiago De Compostela, Spain, Angel Climent, Miguel IVO, Med Oncol Dept, Valencia, Spain, Gonzalez-Billalabeitia, Enrique Univ Murcia, IMIB, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, Murcia, Spain, Gonzalez-Billalabeitia, Enrique Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, Lainez, Nuria Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain, Lambea, Julio Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain, Pablo Maroto, Jose Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain, Jose Mendez-Vidal, Maria Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain, Montesa, Alvaro Hosp Reg Malaga, Med Oncol Dept, Malaga, Spain, Rodriguez, Angel Hosp Leon, Med Oncol Dept, Leon, Spain, Zambrana, Curro Hosp Univ Infanta Sofia, Med Oncol Dept, San Sebastian De Reyes, Spain, Sanofi
مصطلحات موضوعية: abiraterone acetate, androgen-deprivation therapy, chemotherapy, enzalutamide, metastatic castration-resistant prostate cancer, radium-223, Androgen deprivation therapy, Increased survival, Docetaxel, Men, Cabazitaxel, 1st-line, Upfront
العلاقة: http://hdl.handle.net/10668/19103Test; https://doi.org/10.1177/1758835920920067Test; 538873800001
-
2
المؤلفون: María José Méndez-Vidal, Enrique Gonzalez-Billalabeitia, Nuria Lainez, Urbano Anido, Álvaro Montesa, Miguel Angel Climent, J. P. Maroto, Javier Puente, Ángel Francisco Zazo Rodríguez, Curro Zambrana, Julio Lambea, A. González-del-Alba
المساهمون: [Gonzalez-del-Alba, Aranzazu] Hosp Univ Puerta Hierro Majadahonda, Med Ongol Dept, Calle Joaquin Rodrigo 2, Madrid 28222, Spain, [Puente, Javier] Hosp Clin San Carlos, CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain, [Anido, Urbano] Complejo Hosp Univ Santiago, Oncol Dept, Santiago De Compostela, Spain, [Angel Climent, Miguel] IVO, Med Oncol Dept, Valencia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Murcia, IMIB, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, Murcia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, [Lainez, Nuria] Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain, [Lambea, Julio] Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain, [Pablo Maroto, Jose] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain, [Jose Mendez-Vidal, Maria] Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain, [Montesa, Alvaro] Hosp Reg Malaga, Med Oncol Dept, Malaga, Spain, [Rodriguez, Angel] Hosp Leon, Med Oncol Dept, Leon, Spain, [Zambrana, Curro] Hosp Univ Infanta Sofia, Med Oncol Dept, San Sebastian De Reyes, Spain, Sanofi
المصدر: Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Therapeutic Advances in Medical Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauمصطلحات موضوعية: Oncology, Radium-223, medicine.medical_specialty, radium-223, medicine.medical_treatment, Docetaxel, Androgen deprivation therapy, Castration resistant, chemotherapy, lcsh:RC254-282, 1st-line, Upfront, Increased survival, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Enzalutamide, 030212 general & internal medicine, Chemotherapy, Cabazitaxel, enzalutamide, business.industry, Abiraterone acetate, Men, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, metastatic castration-resistant prostate cancer, chemistry, 030220 oncology & carcinogenesis, androgen-deprivation therapy, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0c26be19d7be0e8eed0ba68bd453c9Test
https://doaj.org/article/75ff313d187749adb79d84a4a14b63f7Test